SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Reports Rising Diranersen Benefit at Two Years

Biogen said new two-year data showed rising clinical benefit for diranersen in early Alzheimer's disease.

BIIB

Related stories